Sponsor

Zhejiang Jingxin Pharmaceutical Co., Ltd.

Clinical research sponsor

Published trials3

Recruiting shown0

Roles1

SourceClinicalTrials.gov

Clinical trials

3 shown

A Randomized, Double-blind, Placebo-controlled Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JX2105 in Healthy Chinese SubjectsNCT06537050 · lead sponsor · 2024-07-01

UNKNOWN

A Clinical Trial to Evaluate Safety, Tolerance and Pharmacokinetics of JX11502MA Capsule in Patients With Schizophrenia.NCT06356389 · lead sponsor · 2022-03-02

COMPLETED

A Safety，Tolerability and Pharmacokinetics Clinical Trial of JX11502MA CapsuleNCT05233657 · lead sponsor · 2020-01-04

UNKNOWN

Sponsor roles

lead sponsor3

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.